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Ethical challenges in the Covid-19 research context: a toolkit for supporting analysis 
and resolution
Covid-19 is compromising all aspects of society including health, political, 
social, economic and educational spheres. In this context, there is a 
premium being placed on scientific research as a source of possible 
solutions, with a situational imperative to carry out investigations at an 
accelerated rate and an additional challenge not to neglect ethical standards 
in a context where doing so may mean the difference between life and 
death. In this paper we offer a rubric for considering the ethical challenges 
in COVID-19 related res arch, in the form of an ethics toolkit for global 
research developed by the University of Edinburgh in collaboration with 
more than 200 global researchers from all over the world (Reid et al., 
2019). This toolkit proposes a frame of reference for the analysis and 
confrontation of ethical conflicts that suggests that the conflict (and its 
solutions) can be found in the integrated analysis of the Place, People, 
Principles and Precedents, considered iteratively throughout the research 
journey. Two case analysis are offered to exemplify the utility of the 
toolkit as a flexible and dynamic tool to promote ethical research in the 
context of Covid-19.Keywords: Covid-19, Research, Ethics, Integrity
Introduction
Covid-19 is a new virus identified in December 2019 due to an aggressive outbreak 
in China (Li et al., 2020). On March 11th WHO declared the outbreak a pandemic and by 
the beginning of May 2020 the virus had reached five continents, leaving dramatic numbers 
of infections and high rates of mortality (WHO, 2020a). At a global level, international 
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organizations and governments have promoted measures to decrease the speed of spread, 
prevent contagion and decrease the number of deaths (United Nations, 2020) through 
promotion of hygiene habits, the use of masks, to more extreme measures such as the 
closure of shops and borders, and isolation or quarantine of entire populations (Brooks et 
al., 2020; WHO, 2020b). Still, in some countries the rate of infection and the number of 
deaths has continued pace, leading to increased global efforts to investigate the virus, 
generate prevention and treatment strategies (Kupferschmidt. & Cohen, 2020).
These measures have brought a series of ethical conflicts at different levels. 
Measures implemented by governments have involved choosing between health outcomes, 
social outcomes and economic outcomes (McKee, & Stuckler, 2020). Frontline health 
practitioners have faced demand that exceeds the amount of resource available in most 
countries and required decisions such as which patients to allow into hospitals and which to 
prioritize for the use of mechanical ventilators (British Medical Association, 2020a). At 
each level, organizations have operated from pre-existing professional ethical guidelines or 
emergency guidelines developed in time of previous natural disasters or emergencies 
(British Medical Association, 2020b; Chiumento et al., 2017; UK Government, 2013, 
2017).  
In this document, we will focus on ethical challenges for research. Due to the global 
crisis that Covid-19 has generated, national and international research agencies have 
launched urgent calls to action (Frontiers, 2020; WHO, 2020c). Although there is an 
undeniable need for research that can quickly provide useful information to deal with the 
current phenomenon, this global humanitarian imperative brings with it an increased 
responsibility and a series of ethical challenges not previously experienced by most 
researchers and communities (Mormina et al., 2020). These potential ethical conflicts in the 
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context of Covid-19 may arise, and indeed change, throughout the research journey (WHO, 
2020d) and require close and iterative attention. 
These ethical challenges are particularly pertinent for the medical sciences. For 
example, the ethical challenge of generating vaccines and recruiting participants to 
participate in clinical trials is evident. It must be considered that, in addition to the pressure 
of the health situation, researchers face the pressure of responding to the political demands 
of funding agencies and governments.  
The challenges are not just limited to the medical sciences, however. Engineering 
sciences also face important ethical dilemmas, for example in the development of new 
technology (e.g., mechanical ventilators) and the question of whether to support 
development for humanitarian use or potential commercial use. Social sciences have a 
critical role in the current situation in developing an understanding of social corollaries of 
the pandemic and of factors that may influence uptake and adherence with preventative 
measures such as physical distancing. Social science research can shape, for better or 
worse, the population's understanding of the problem, adherence to preventive measures 
and the adequate treatment of the emotional consequences of the pandemic and the social 
measures taken to confront it (e.g., confinement) (Dalton et al., 2020). 
In this short document, we propose that a global research toolkit (Reid et al., 2019) 
– developed in the context of a project at the University of Edinburgh, in collaboration with 
more than 200 global researchers from more than 60 countries and different disciplines – 
can be useful to assist researchers in analyzing the dynamic ethical challenges as they 
unfold throughout this pandemic (see https://www.ed.ac.uk/global-health/doing-ethical-
global-research-together). This toolkit, rather than offering a rigid guide to ethical 
regulations, offers a flexible frame of reference that has the ambition to promote ethical 
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reflection and accountability within research teams. The toolkit proposes two fundamental 
axes of analysis: iterative ethical analysis throughout the research journey, and ethical 
analysis based on the 4Ps model (See figure 1).
Ethics throughout the research Journey
The idea of ethics throughout the research journey arises in opposition to the idea 
that research ethics is only associated with the process of applying for project approval 
from an ethics committee. On the contrary, ethical reflection and considerations must be 
present during the entire research journey. Ethical accountability starts before the project 
begins by considering the research culture of our institution and the ethics of the germinal 
ideas of the study; it extends beyond the life of the project to the legacy that our research 
leaves on the communities involved and on the intended (and unintended) recipients.
As seen in Figure 1, at least 13 different stages are recognized in the research 
journey and connected through an iterative process of reflection. In the current context of 
Covid-19, the rapid execution of research processes has been prioritized encouraging the 
normal steps of the investigation to be carried out faster than usual (Kupferschmidt, & 
Cohen, 2020). We offer an analysis and some examples of ethical conflicts in the different 
stages of the research journey. Our desire is not to offer an exhaustive list of all the possible 
ethical challenges since these will depend on the context of each investigation, we simply 
offer a framework for the analysis of real cases. We have grouped the 13 stages into three 
sections of the research journey.  
Initial section: From research culture to ethics application 
This first section looks at the beginning stages of the research included considering 
the research culture of the organizations, the development of the research idea, the team and 
partnership development, and the preparation of grant and ethical applications (see figure 1)
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In the Covid- 19 context the development of the idea, the formation of a work team, 
the elaboration of the proposal and even the process of ethical application is hastier. 
Though speed is essential ethical rigor should not be relaxed since, in a context such as 
Covid-19, unethical or negligent action could have serious consequences for research 
participants and for society in general (Mormina, et al., 2020; WHO, 2020d).
While there is evidence of scientific communities  from different countries coming 
together  to establish international research teams, there are also tensions  as  the research 
space has been one of  competition in a system whose traditions rewards competition and 
encourages institutions and individuals to take advantage of opportunities for financial gain 
and career progression. 
Ensuring that there is a collective agreement and collective benefits from working 
together is essential, do researchers working in Universities that are not highly research 
focused feel pressure to participate because funding is desperately needed?  Are the 
research questions have emerged from the local context or have they been superimposed on 
the context?
Preparing applications for grants and ethics committees also become a major 
challenge, both for applicants - who must plan investigations in a short time and without 
much evidence of health emergencies of this magnitude - as well as for review committees 
and ethical committees - who have a high responsibility to accept or reject projects 
potentially beneficial to humanity.  Committees are looking for evidence of co-creation of 
design and of clear requests for engagement by all partners but speed may mean that these 
essentials are recorded as positive when in fact they are still in progress 
Middle stages: fieldwork and analysis of results
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This stage includes the data collection process, the project delivery, but also the 
process of analysis and writing of reports. There are multiple ethical challenges in the  
recruitment process with  the population and the researchers at risk of becoming ill, 
experiencing serious side effects or directly at risk of dying (Van Griensven, 2016); as 
such, it is essential that researchers ask, for example, how do we promote an informed 
consent process in a population highly expectant of the potential benefits of research and 
how do we manage the expectations of the participants and the community? How do we 
interview in a socially responsible risk free way both for the researchers and for the 
participants? Physical distancing an essential preventive measure of Covid-19 also poses 
ethical challenges, particularly in relation to the reliability and validity of the data 
collection process. This is especially salient when questionnaires or interviews are 
conducted by telephone or internet, which requires researchers to consider whether those 
without internet connection are being  excluded from research and how this sampling bias 
may affect the internal and external validity of the results. 
There are also some communities, such as refugee communities, whose conditions 
place them at heightened risk of infection, and also creates increased vulnerability when it 
comes to informed consent to participate in trials. Desperation, panic, pre-existing trauma, 
mental health vulnerabilities and poor communication in a Refugee Camp setting may 
make it difficult for residents to feel that they have a choice in participating in the research, 
or indeed, to ascertain the difference between health services offering healthcare and 
researchers trialling new treatment options. We believe all these issues should be 
considered in the analysis of result and in the writing process, with particular reference to 
the internal and external validity of results
Final stages: from the dissemination of results to the analysis of the legacy
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We strongly believe that ethical issues sometimes resulting in ethical conflicts can 
be present even after research reports have already been written or even published. This is 
an issue often neglected by research teams. For this reason, we propose the importance of 
the process of analysis, dissemination, exchange of information and application to practice. 
For example, if a vaccine is found soon, how will that information be handled? Will 
humanitarian or commercial interests be privileged for the dissemination of this 
knowledge? The answers to these questions will also undoubtedly be influenced by ethical 
conflicts that may arise from considerations of the impact and legacy of the study. 
No matter what are of research, scientists in all areas have a duty to transmit 
information in a clear, accessibl , quick and reliable way, sharing negative results as well 
as positive outcomes. This challenge has been evident across different media during the 
pandemic, with calls on the scientific community to speak up but also to speak responsibly 
with the understanding that such reports can support positive responses but can also 
generate panic reactions and reinforce myths and stereotypes. Many scientists are not 
practiced at translating their research into lay-language that can be understood clearly by 
the broader community and yet it is our ethical responsibility to do so. Open access 
publication has also become key in sharing findings quickly with the research community 
and submitting them to the scrutiny of peer review. Then there is the question of 
commercialisation and the ethics of taking out patents on drugs or vaccines that may 
prevent equitable access. 
__PLEASE INSERT FIGURE 1 HERE_
The 4Ps model
Page 7 of 18






























































For Peer Review Only
The Global Research toolkit proposes that the analysis of throughout the research 
journey  it is necessary to look at complementary aspects of the research endeavor to 
ascertain the nature of challenges and potential solutions. 
The 4P’s model states that ethical challenges can be helpfully analyzed by 
considering Place, People, Principles, and Precedents. It is proposed that ethical challenges 
are based on these 4 elements, but that solutions can also be found in them.
Place. Which includes contextual aspects – cultural, political, economic, health – 
where the research is being carried out, or where its results are relevant. For example, any 
ethical situation related to Covid-19 will require a contextualized approach as conducting 
research in countries where the pandemic is uncontrolled will have different requirements 
and pose different challenges to conducting research in countries where the most acute 
phase has already passed (or has not yet started). A solution may be effective in one 
context, but not in another. There are also risks of ignoring key ethical issues in name of an 
emergency or humanitarian research when in fact we should be more, not less, accountable 
for our actions – this is a challenge perhaps familiar to global health researchers but less so 
to the many researchers entering this global stage for the first time. During a global 
pandemic, there are increased ethical challenges associated with working with highly 
vulnerable populations, either because they are fighting the virus or because of fear and 
panic associated with trying to avoid the virus may make communities and individuals less 
able to make clear and reasoned decisions. It is important that we ask ourselves how we can 
recruit participants in this context without taking advantage of their vulnerability?
People. Which includes those involved (research team, funding sources, institutions, 
international partners, potential participants, potential beneficiaries, etc.). The Covid-19 
crisis requires international, interdisciplinary and inter-sector collaboration, but that 
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collaboration brings with it differences in research power that require consideration. For 
example, the need to ensure the wellbeing of research participants in the context of a 
pandemic is an evident challenge, where the understanding of research procedures is sought 
without violating the principles of informed consent. Additionally, in international research, 
important questions include how to determine the country where the first tests of the 
vaccine will be carried out without falling into neo-colonialist practices? On the other hand, 
when developing s lutions to ethical conflicts, it is important to consider the organizations, 
people, regulatory entities or colleagues that could help us or advise us on how to properly 
face these issues.
Principles. This refers to the importance of considering, at all times, the principles 
and values that should guide ethical research. For example, the balance of risk-benefit is an 
obvious challenge to potential candidates to test a vaccine. Economic interests vs. 
humanitarian interests associated with the dissemination of relevant new knowledge also 
come into play. We can add the difficulties of establishing procedures with scientific rigor 
in these contexts of urgency and limited resources.
Precedent. This element refers to the need to analyze past experiences of similar 
ethical conflicts that can help us understand and resolve current ethical conflicts. It is 
especially relevant to review the current ethical regulations and the available academic 
material that may help us face the conflict. At the same time, researchers have the challenge 
of – based on their own current experience – ‘generating a precedent’ of ethical conduct in 
research that helps future researchers face similar ethical conflicts. This point is particularly 
useful to the scientific community in the future when face ethical challenges in situations 
similar to the current Covid-19 crisis.
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In the following section, we offer two examples on how to apply this analysis 
framework in the resolution of a possible ethical conflict. The end is purely illustrative as 
the proposed solution to the ethical conflict is will depend on the specific context in which 
the challenge arises and the rapidly changing circumstances as the project progresses.
Case analysis 1
The case to be presented mainly covers the difficulty of establishing collaborative 
relationships between research teams. It is clear that the complexity of the current world 
health crisis requires collaborative, interdisciplinary, inter-university, inter-sectoral and 
inter-cultural work. However, sometimes the personal interests of research teams or 
universities may conflict with th  scientific and humanitarian interest of having new 
relevant knowledge to face the pandemic. As we have already outlined, this solution only 
seeks to exemplify the reasoning behind the toolkit, we do not expect this solution to be 
generalizable to other contexts, beyond the illustrative exercise. See table 1.
_PLEASE INSERT TABLE 1_
Case analysis 2
The second case analysis addresses the ethical conflict in clinical trials where new 
medical procedures are tested, in this case a vaccine for Covid-19. The case is located in a 
refugee camp where there are low resources and a vulnerable population, with high risk of 
contagion and with high expectation of receiving help. In this context, power differences 
between researchers and potential participants can easily lead to exploitation of the 
community. In the case, we analyze issues such as the balance between risk vs. benefit, 
informed consent, language barriers and the following of ethical protocols and local 
regulations. Like the previous case, the objective is merely illustrative, and we do not 
expect this solution to be applicable in all cases. We hope that the two cases serve as 
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examples and are useful for the reader to analyze their own ethical conflicts in their current 
research context. Please see table 2.
_PLEASE INSERT TABLE 2_
Discussion
The current global situation requires the collective efforts of many different agents 
to face the pandemic. Doctors, nurses, and other front-line practitioners and key workers 
are exerting immense effort in tackling the effects of the virus (Legido-Quigley, Mateos-
García, Campos, Gea-Sánchez, Muntaner, & McKee, 2020). This effort must be 
complemented by scientists from all disciplines, collaborating with new evidence of 
preventive measures and treatments to deal with Covid-19 and its associated ills, including 
the impact on mental health of individuals and the longer term impacts on the social, 
economic and political structure of societies (Inchausti et al., & Dimaggio, 2020; 
Kupferschmidt. & Cohen, 2020)
We believe that scientists should respond to this call with haste and responsibility, 
without neglecting compliance with ethical standards consistent with contemporary science 
practice and compatible with international ethical regulations.
In this document, we offered a toolkit – developed collaboratively with researchers 
around the world – that can help researchers analyze and search for solutions to everyday 
ethical conflicts. We have briefly explained the toolkit and provided a hypothetical case 
analysis. Our outline here has been brief, offering illustrations in the form of case studies to 
provide the reader with general idea of the application of the model. The original source 
provides more detailed information on the toolkit and its uses (Reid et al., 2019). 
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Table 1. Case analysis 1




Ethical Reflection Ethical Response 
The research of Dr. AV and his 
team seeks to contribute to the 
development of a vaccine 
against Covid-19.
Dr. AV knows that the research 
would benefit greatly if he 
established collaborative work 
with Dr. CB's team.
Doctors AV and CB come from 
two major universities 
competing for leadership in the 
area. In recent years, their 
relationship has been 
deteriorated by conflict of 
interest (research funds, 
authorship and commercial 
rights).
Dr. AV is unsure whether to 
start collaborative work with Dr. 
CB despite the benefits this 
would bring for research and, 
eventually, for humanity
0. Pre-Stage 










6. Data Collection 
Begins
7. Project Develops 
and Ends 
8. Data Analysis 




11. Translation into 
Practice 
12. Legacy and 
Impact
Place: Both research teams 
work at rival universities 
located in neighboring 
countries. The culture in both 
universities enhances 
competition more than 
collaboration.
People: Dr. AV and CB 
work in the same area, the 
last 20 years have competed 
for the same research funds. 
In the last congress of their 
specialty they were involved 
in a heated public altercation
Principles: Dr. AV’s 
dilemma is whether to 
privilege his personal 
interests (and that of his 
university) or ensure the 
progress of research in a 
global health emergency.
Precedents: What are the 
national and international 
regulations in this regard? 
Has this happened before? 
How has it been resolved?
Place: Both rival universities 
have worked together in the past. 
There is a cooperation agreement 
that offers suggestions for 
regulating collaboration between 
them.
People: It is important to ask: 
who on Dr AV and Dr CB's teams 
or universities could help 
overcome this impasse? Is there 
someone from other universities 
or research teams who can help?
Principles: Dr. AV understands 
the interest of humanity over 
personal interests are more 
important, but at the same time he 
is aware that conflicts of interest 
could cause the project to fail, 
even working together with Dr 
CB.
Precedents: There are 
antecedents of similar situations 
among other investigation teams 
that have been mediated by a 
collegiate international 
organization.
Dr. AV discussed the issue with his 
research team. All agreed on the 
undeniable benefit of working with Dr. 
CB's team.
One of the team members suggested also 
inviting Dr AS to join the project. Dr AS 
has worked in collaborations with both 
teams for the last 5 years, so could offer 
a technical contribution, but also act as a 
‘bridge’ and potential mediator.
Later, Dr. AV reviewed the 
collaboration agreement between the 
two universities which highlighted that 
the process for determining authorship 
and commercial rights of the findings 
was well regulated.
In addition, Dr AV asked for a quickly 
advice to the international scientific 
society of which he and Dr CB are part 
of for guidance.
As such, Dr AV invited Dr CB and Dr 
AS to join the project. Before 
commencing, they defined the limits of 
the relationship, signing a collaboration 
contract (which specified roles, 
functions, authorship and possible 
commercial rights).
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Table 2. Case analysis 2
Ethical issue Part(s) of the 
research Journey? 
Understanding the dilemma Ethical Reflection Ethical Response 
You are working in a refugee 
camp with 2,000 people living a 
context of poverty, 
overcrowding, weak health 
system, and difficulties 
accessing basic services. Under 
these conditions, the risk of 
transmission of Covid-19 is 
high.  A colleague –working on 
a vaccine – asks you to arrange 
clinical trials in the refugee 
camp. You are unsure of the 
appropriateness of the request, 
given the level of vulnerability 
of the population. Your main 
concern is that the community 
may not understand the scope of 
the vaccine test, or the 
difference between a trial and a 
proven treatment, and may not 
be in a position to provide 
informed consent, and may have 
expectations that exceed reality. 
You do not want to exploit the 
community
0. Pre-Stage 










6. Data Collection 
Begins
7. Project Develops 
and Ends 
8. Data Analysis 




11. Translation into 
Practice 
12. Legacy and 
Impact
Place:  In the camp, preventive 
measures (hygiene and social/ 
physical distancing) are not 
possible due to overcrowding and 
lack of basic services – likely 
rates of infection will be high and 
services low. A successful 
vaccine could make a very 
significant humanitarian 
differenc .  Previous experience 
of research is low whereas access 
to humanitarian aid services is 
high – these could be confused.
People:  Refugees are anxious for 
help. Expectations are high, and 
understanding of the implications 
of clinical trials is low
Principles: The importance of 
Covid-19 clinical trials are 
known, but given the associated 
risks, informed consent is of 
utmost importance.
Precedents:  Previous studies 
clearly show that vulnerable 
populations have exaggerated 
expectations of the benefits of 
clinical trials (e.g., Weinfurt et al., 
2005)
Place:  In the camp, there is 
a hierarchical structure with 
leaders validated/respected 
by the community
People:  Within the leaders, 
there are individuals with 
basic knowledge of medicine 
who are willing to explain 
the scope of trial to the 
population.
Principles:  You are aware 
that the community has to 
understand the risks vs. 
benefits of trial. Your 
intention is to explain in a 
clear and transparent way 
that is understood by the 
community.
Precedents: There are 
protocols for conducting 
vaccine trials in vulnerable 
settings and for gaining 
culturally sensitive informed 
consent (e.g., Bonhoeffe et 
al., 2013). In addition, 
countries have their own 
regulations that must be 
reviewed before proceeding.
The research team meets with community 
leaders to explain the research, the risks, 
and potential benefits. The discussion is 
led by a member of the research team who 
speaks the local language. Community 
leaders offer to collaborate in the process 
of explaining the scope of the research to 
the community.
Workshops are held in the community 
where the research risks and benefits are 
explained. This is conducted in the local 
language, supported by an explanatory 
video.
After receiving clear information some 
participants decide to freely consent 
(knowing that they also have a right not to 
participate) and others choose not to.
Those interested in taking part will 
participate in individual interviews to 
ensure they understand the risks and can 
provide informed consent freely. After 
receiving clear information some 
participants decide to freely consent 
(knowing that they also have a right not to 
participate) 
In addition, the recruitment process 
respects local protocols and is in 
accordance with what is required by the 
local authorities.
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